Market revenue in 2023 | USD 315.1 million |
Market revenue in 2030 | USD 872.0 million |
Growth rate | 15.7% (CAGR from 2023 to 2030) |
Largest segment | Consumables |
Fastest growing segment | Consumables |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Consumables, Instruments |
Key market players worldwide | Thermo Fisher Scientific Inc, BD, Danaher Corp, Terumo Corp, STEMCELL Technologies, Bio-Rad Laboratories Inc, Merck KGaA, Agilent Technologies Inc, Corning Inc, Akadeum Life Sciences |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell separation market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 63.88% in 2023. Horizon Databook has segmented the India cell separation market based on consumables, instruments covering the revenue growth of each sub-segment from 2018 to 2030.
In the past few decades, India has become a hub of pharmaceutical and biotechnology and has gained global attention due to the presence of skilled & knowledgeable manpower and low capital investments. Owing to the presence of rich resources and a large pool of existing R&D institutions in the country, India has become one of the major areas for setting up research laboratories and manufacturing units by multinational companies.
In addition, public sector enterprises such as the Biotechnology Industry Research Assistance Council (BIRAC) and the Department of Biotechnology (DBT) have promoted R&D in the field of biotechnology across the country. Thus, rapidly growing pharmaceutical and biotechnology industries and frequent government initiatives to boost R&D activities in the country are expected to create lucrative opportunities for the growth of the cell separation market.
Furthermore, increasing research in the field of stem cells and cancer is further anticipated to create lucrative opportunities. For instance, in February 2020, the Global Institute of Stem Cell Therapy and Research (GIOSTAR), a regenerative medicine provider, established a stem cell/cancer research center in India.
Horizon Databook provides a detailed overview of country-level data and insights on the India cell separation market , including forecasts for subscribers. This country databook contains high-level insights into India cell separation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account